Policies by Subject Area

Research

• 400-10: Academic, Legal and Financial Policies of Contracts and Grants

  Ensures appropriate scientific and financial management of research, training, and other extramurally funded projects.

• 400-11: Eligibility to Submit Proposals for Extramural Funds (PI Status)

  Outlines eligibility to submit proposals for extramural funds.

• 400-12: Contract and Grant Solicitation and Acceptance or Execution

  Defines the authority to solicit and accept or execute contracts or grants for instruction or research.

• 400-16: Award Acceptance and Execution of Contracts and Grants

  Defines responsibilities for the review, acceptance, and execution of contracts and grants.

• 400-19: Research Involving Human Subjects

  Mandates compliance with all federal regulations, state laws, and University of California policies governing the use of human subjects in research.

• 400-20: Research and Instruction Using Animal Subjects

  Ensures institutional compliance with all applicable federal and state laws and regulations and University policies governing the use of animals in research.

• 400-21: Housing of Animals for Research

  Mandates that all animals used for research at UCSF must be housed in designated animal care facilities in order to comply with federal regulations.

• 400-22: Clinical Trials Registration & Reporting

  Establishes UCSF standards for Clinical Trial registration to comply with Food and Drug Administration requirements and to secure the ability to publish clinical trial results under the International Committee of Medical Journal Editors standards.

• 400-23: Patents

  Establish the rights of the various parties interested in potentially patentable inventions.

• 400-24: Integrity of Research

  Research at UCSF must be conducted in a manner appropriate to its academic goals to protect and maintain the integrity of research and of the institution.

• 400-25: OnCore Utilization and APeX Billing Review for Clinical Trials

  Requirements to track research study participants and events in OnCore and APeX; expectations for compliance with internal control standards to ensure integrity of billing procedures for clinical trials.